Reporter Staff
| This email address is being protected from spambots. You need JavaScript enabled to view it.2022 in review: In case you missed these stories
From innovative teaching approaches to research accomplishments, opportunities for artistic expression and more, there’s no shortage of stories to tell about what’s happening at UAB. Review some of the year’s best below, and visit uab.edu/reporter and uab.edu/news to read hundreds more.
2022 in review: Onward and upward
The university achieved innumerable accomplishments this year, including two program 50th anniversaries, a milestone gift to the College of Arts and Sciences, and the announcement of a new conference for UAB Athletics.
2022 in review: A banner Blazer year
Programs across the university, from athletics to academics to patient care and more, were recognized on the national and international level in 2022, highlighting UAB’s continued commitment to excellence and achievement as outlined in Forging the Future, UAB’s strategic plan.
2022 in review: UAB’s gold-medal performance
Day after day during the World Games, contributions from Blazers made it possible to make athletes’ dreams come true and entertain fans while giving them a peek at the wealth of talent and creativity nurtured on UAB’s campus.
Help us find out by joining our study at UAB You may be eligible to participate in the PRECISION-BP research study investigating the effects of Sacubitril/Valsartan or Valsartan on your body’s 24-hour rhythm of a hormone in your blood called natriuretic peptides. This hormone and the study medications are related to the heart. Eligible participants must be obese (BMI: 30-45 kg/m2) men and women, have high blood pressure, and have no history of heart or kidney problems. The study involves wearing a blood pressure monitor for 24 hours, 24-hour inpatient visits at UAB hospital, taking medications, and collecting blood and urine samples. Meals will be provided at no cost. Participants will be compensated $575 for completing the study visits. Please e-mail Nehal at PRECISION-BPSTUDY@uabmc.edu or call us at 205-934-7173 if you are interested
Are you a healthy African American between the ages of 18 and 60?
You may be eligible to participate in a research study looking at the effects of sacubitril/valsartan on how your body handles insulin and glucose. This medication is related to blood pressure and is safe to take with or without hypertension. Eligible participants must be healthy men and women, African American, and have no history of diabetes, heart disease or kidney problems. The study involves performing some exercise, taking sacubitril/valsartan, and collecting blood samples. Participants will be compensated $675 for completing all the visits. To participate, please contact Haley at 205-975-5825 or email us at nauticalstudy@uabmc.edu.
2022 in review: Our best photos of the year
Each year, UAB’s official photographers capture thousands of images as they document the incredible variety of events and personalities that make up our community. Here are some of our favorite photos from the past 12 months.
4 honored with Provost’s Awards for Faculty Excellence
Ana Oliveira, Sami Raut, Lisa McCormick and Meena Nabavi demonstrated extraordinary commitment to engaging undergraduate students in service learning, undergraduate research and education-abroad experiences.
Beginning Jan. 25, 2023, the National Institutes of Health will implement a new data management and sharing policy, which will increase the rigor, reproducibility and transparency of research and create open access to data.
Do you have Type 2 Diabetes and overweight
The University of Alabama at Birmingham, Department of Nutrition Sciences, in collaboration with Novo Nordisk, is conducting a 78 week research study to look into how well semaglutide once weekly medicine works in participants with obesity and type 2 diabetes
Qualified participants will receive study drug free of charge and may be compensated for time and travel. For more information, and to see if you might be eligible to join, please contact (205) 996-4015 or email at ccnrn@uab.edu.
